These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20194444)

  • 41. [Digital blood flow measurement by venous occlusion plethysmography in Raynaud's phenomenon. Value of the rewarming test].
    Cristol R; Debray J
    J Mal Vasc; 1986; 11(1):85-9. PubMed ID: 3944527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary function in patients presenting with Raynaud's phenomenon without an underlying connective tissue disease. A prospective, longitudinal study.
    Aalbers R; Groen H; Postma DS; Van der Mark TW; Wouda AA; Reig RP; Kallenberg CG
    J Rheumatol; 1989 Jan; 16(1):36-41. PubMed ID: 2785598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Raynaud's phenomenon. Photoelectric plethysmography of the fingers of persons with and without Raynaud's phenomenon during cooling and warming up.
    Wouda AA
    Acta Med Scand; 1977; 201(6):519-23. PubMed ID: 878907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Reestablishment of the clinical diagnosis in vascular acrosyndromes].
    Vayssairat M; Baudot N; Priollet P
    J Mal Vasc; 1988; 13(1):57-9. PubMed ID: 3346618
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Laser Doppler flowmeter and standardized thermal test in normals and Raynaud's phenomenon.
    Boccalon HJ; Marguery MC; Ginestet MC; Puel PF
    Int Angiol; 1987; 6(2):107-18. PubMed ID: 3323348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical analysis of 79 pulmonary arterial hypertension cases from 1892 connective tissue disease patients].
    Lei YX; Zhang X; Cui Y; Dong GF; Luo RQ
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(41):2934-7. PubMed ID: 20137654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessing recovery after cold challenge and thumb involvement can help to rule out systemic sclerosis in patients presenting with Raynaud's phenomenon.
    van Roon AM; van Roon AM; Stel AJ; Bootsma H; Smit AJ; Mulder DJ
    Scand J Rheumatol; 2020 Mar; 49(2):137-140. PubMed ID: 31637927
    [No Abstract]   [Full Text] [Related]  

  • 49. Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud's Phenomenon.
    Ingegnoli F; Gualtierotti R; Orenti A; Schioppo T; Marfia G; Campanella R; Mastaglio C; Meroni PL; Boracchi P
    J Immunol Res; 2015; 2015():371960. PubMed ID: 26075287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Differences in the prevalences of Raynaud's phenomenon in general populations living in a mountain area and in a plain area].
    Komura Y; Yoshida H; Nagata C; Fujita S; Mirbod SM; Inaba R; Iwata H
    Nihon Koshu Eisei Zasshi; 1992 Jul; 39(7):421-7. PubMed ID: 1504336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of mental and physical health between patients with primary and secondary Raynaud's phenomenon Category: Article.
    Fábián B; Fábián AK; Bugán A; Csiki Z
    J Psychosom Res; 2019 Jan; 116():6-9. PubMed ID: 30654995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Digital gangrene in a patient with primary Raynaud's phenomenon.
    Ravindran V; Rajendran S
    J R Coll Physicians Edinb; 2012 Mar; 42(1):24-6. PubMed ID: 22441059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Part I: Epidemiology, pathophysiology, and clinical considerations of primary and secondary Raynaud's phenomenon.
    Curtiss P; Svigos K; Schwager Z; Lo Sicco K; Franks AG
    J Am Acad Dermatol; 2024 Feb; 90(2):223-234. PubMed ID: 35809798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon.
    Ruaro B; Smith V; Sulli A; Pizzorni C; Tardito S; Patané M; Paolino S; Cutolo M
    Front Pharmacol; 2019; 10():360. PubMed ID: 31073287
    [No Abstract]   [Full Text] [Related]  

  • 55. The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon.
    Wollersheim H; Thien T; Hoet MH; Van Venrooy WJ
    Eur J Clin Invest; 1989 Dec; 19(6):535-41. PubMed ID: 2515974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential diagnosis of Raynaud's phenomenon based on modeling of finger thermoregulation.
    Ismail E; Orlando G; Corradini ML; Amerio P; Romani GL; Merla A
    Physiol Meas; 2014 Apr; 35(4):703-16. PubMed ID: 24622281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Raynaud's disease and Raynaud's phenomenon in connective tissue diseases].
    Sicińska J; Rudnicka L
    Pol Arch Med Wewn; 2002 Oct; 108(4):1011-22. PubMed ID: 12642947
    [No Abstract]   [Full Text] [Related]  

  • 58. Increased mean platelet volume in primary Raynaud's phenomenon.
    Shemirani AH; Nagy B; Takáts AT; Zsóri KS; András C; Kappelmayer J; Csiki Z
    Platelets; 2012; 23(4):312-6. PubMed ID: 21942753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Digital thermography of the fingers and toes in Raynaud's phenomenon.
    Lim MJ; Kwon SR; Jung KH; Joo K; Park SG; Park W
    J Korean Med Sci; 2014 Apr; 29(4):502-6. PubMed ID: 24753696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Raynaud's phenomenon: from molecular pathogenesis to therapy.
    Prete M; Fatone MC; Favoino E; Perosa F
    Autoimmun Rev; 2014 Jun; 13(6):655-67. PubMed ID: 24418302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.